Sector consensus Legend Biotech Corporation

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 08/07/2025 BST			5-day change	1st Jan Change
37.49 ^USD	+4.52%		+3.31%	+15.21%

07-03	UBS Lowers Price Target on Legend Biotech to $54 From $60, Maintains Buy Rating	MT
06-30	Legend Biotech Provides Update on REMS for Currently Approves BCMA- and CD19-Directed Autologous Chimeric Antigen Receptor T Cell Immunotherapies	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Average Target P.	Ecart obj. / dr	Nbr of analysts
LEGEND BIOTECH CORPORATION		US$75.07	+100.24%	20
ARGENX SE		€667.33	+43.79%	16
WUXI APPTEC CO., LTD.		CN¥83.08	+18.02%	18
BIONTECH SE		US$116.8	+22.55%	21
INSMED INCORPORATED		US$113.22	+17.76%	18
SUMMIT THERAPEUTICS INC.		US$25.65	+52.36%	9
WUXI BIOLOGICS (CAYMAN) INC.		HK$27.24	+16.12%	26
AKESO, INC.		HK$96.14	-4.06%	20
GENMAB A/S		DKK 1,936.2	+42%	16
EXELIXIS, INC.		US$45	+3.42%	19
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.		HK$321.97	-6.13%	16
VERONA PHARMA PLC		US$119.09	+37.11%	11
MADRIGAL PHARMACEUTICALS, INC.		US$423.14	+47.17%	14
PHARMAESSENTIA CORPORATION		NT$700.5	+33.68%	4
BIOCON LIMITED		₹379.2	+2.67%	20
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.		CN¥99.04	+7.28%	2
NUVALENT, INC.		US$117.3	+48.91%	10
SINOCELLTECH GROUP LIMITED	-	CN¥49	-38.11%	2
REMEGEN CO., LTD.		HK$36.44	-41.28%	15
Average		285.86	+21.24%	15
Weighted average by Cap.		305.81	+24.73%	16